Opinion on Therapy Area in France

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Genta: Genasense on a rocky road

Sanofi-Aventis [SAN.PA] told Genta [GNTA] that it intended to end the collaboration between the two for the development of Genasense back in November 2004 after the drug failed to gain approval for chronic lymphoid leukemia, malignant melanoma and multiple myeloma. Although the drug remains in clinical trials, Genasense is unlikely to fulfill the commercial potential it once promised.

Published By Datamonitor
11 May 2005
ResearchWire
ResearchWire

Gastric cancer: 10 times more common in Japan than US

Published By Datamonitor
05 Dec 2001
ResearchWire
ResearchWire

European oncology: UK to see 5% annual growth in cancer incidence by 2012

Published By Datamonitor
21 Jan 2005
ResearchWire
ResearchWire

Epilepsy: 6.3 million cases in 2008

Published By Datamonitor
07 Aug 2001
ResearchWire
ResearchWire

Dyslipidemia: US makes up two-fifths of world sales

Published By Datamonitor
27 Apr 2001
ResearchWire
ResearchWire

Dyslipidemia: sales to increase 50% by 2007

Published By Datamonitor
04 May 2001
ResearchWire
ResearchWire

Cytotoxic antibiotics: sales down 4% by 2007

Published By Datamonitor
11 Jun 2001
CommentWire
CommentWire

CryoCor: competing in cardiac cryoablation

Published By Datamonitor
17 Aug 2001
ResearchWire
ResearchWire

Colorectal cancer: sales to top $1 billion by 2007

Published By Datamonitor
08 May 2001
ResearchWire
ResearchWire

Cardiovascular drugs: hypertension leads, but others catching up

Published By Datamonitor
28 Mar 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | » »|

No help is available.